Overview

This trial is active, not recruiting.

Conditions small for gestational age (disorder), pre-eclampsia
Sponsor Assaf-Harofeh Medical Center
Start date September 2009
End date January 2014
Trial size 300 participants
Trial identifier NCT02031393, 217/13

Summary

The purpose of this study is to determine whether we can establish different markers suc as mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood and more un the first trimester, in order to screen for twin pregnancies that are more likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Observational model case control
Time perspective prospective
Arm
will be followed 11-14 weeks and 19-28 weeks of gestation and after birth
will be followed 11-14 weeks and 19-28 weeks of gestation and after birth

Primary Outcomes

Measure
The development of preeclampsia
time frame: after delivery

Secondary Outcomes

Measure
intra uterine growth restriction
time frame: after delivery

Eligibility Criteria

Female participants from 18 years up to 50 years old.

Inclusion Criteria: - pregnant women from 11 -14 weeks of gestation Exclusion Criteria: - nuchal thickness above 3 mm, - Chronic hypertension, - thrombophilia, - Diabetes

Additional Information

Official title Establishing First Trimester Sonographic, Biochemical and Clinical Markers for the Identification of High Risk Twin in the First Trimester
Trial information was received from ClinicalTrials.gov and was last updated in January 2014.
Information provided to ClinicalTrials.gov by Assaf-Harofeh Medical Center.